期刊的影响因子--文章列表

期刊文章列表
Binghe Xu¹，Qingyuan Zhang²，Xichun Hu³，Qing Li¹，Tao Sun⁴，Wei Li⁵，Quchang Ouyang⁶，Jingfen Wang⁷，Zhongsheng Tong⁸，Min Yan⁹，Huiping Li¹⁰，Xiaohua Zeng¹¹，Changping Shan¹²，Xian Wang¹³，Xi Yan¹⁴，Jian Zhang³，Yue Zhang²，Jiani Wang¹，Liang Zhang⁴，Ying Lin¹⁵，Jifeng Feng¹⁶，Qianjun Chen¹⁷，Jian Huang¹⁸，Lu Zhang¹⁹，Lisong Yang¹⁹，Ying Tian¹⁹，Hongyan Shang¹⁹（Department of Medical Oncology and State Key Laboratory of Molecular Oncology，National Cancer Cener/Cancer Hospital，Chinese Academy of Medical Sciences and Peking Union Medical College；Department of Medical Oncology，Harbin Medical University Cancer Hospital；Department of Medical Oncology，Fudan University Shanghai Cancer Center；Department of Galactophore，Liaoning Cancer Hospital & Institute；Department of Oncology，the First Hospital of Jilin University；Department of Galactophore，Hunan Cancer Hospital；Department of Galactophore，Linyi Cancer Hospital；Department of Breast Medical Oncology，Tianjin Medical University Cancer Institute & Hospital；Department of Breast Disease，Henan Breast Cancer Center，the Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital；Department of Breast Oncology，Beijing Cancer Hospital；Breast Cancer Center，Chongqing University Cancer Hospital；Department of Breast and Thyroid Oncology，Affiliated Hospital of Jining Medical University；Department of Medical Oncology，Run Run Shaw Hospital，Affiliated Hospital of Zhejiang University；Department of Head and Heck Oncology，West China Hospital，Sichuan University；Department of Thyroid & Breast Surgery，the First Affiliated Hospital of Sun Yat-sen University；Department of Medical Oncology，Jiangsu Cancer Hospital；Department of Galactophore，Guangdong Hospital of Traditional Chinese Medicine；Department of Oncological Surgery，the Second Affiliated Hospital，Zhejiang University School of Medicine；Taizhou EOC Pharma Co.Ltd.）.Entinostat, a class Ⅰ selective histone deacetylase inhibitor, plus exemestane for Chinese patients with hormone receptor-positive advanced breast cancer：A multicenter, randomized, double-blind, placebo-controlled, phase 3 trial[J].Acta Pharmaceutica Sinica B,2023,第5期 Damijan Knez¹，Daniel Diez-Iriepa^2,3，Mourad Chioua^2,3，Andrea Gottinger⁴，Milica Denic⁵，Fabien Chantegreil⁵，Florian Nachon⁵，Xavier Brazzolotto⁵，Anna Skrzypczak-Wiercioch⁶，An?e Meden¹，Anja Pi?lar¹，Janko Kos¹，Simon ?akelj¹，Jure Stojan⁷，Kinga Sa?at⁸，Julia Serrano⁹，Ana Patricia Fernández⁹，Aitana Sánchez-García¹⁰，Ricardo Martínez-Murillo⁹，Claudia Binda⁴，Francisco López-Mu?oz¹¹，Stanislav Gobec¹，José Marco-Contelles²（University of Ljubljana，Faculty of Pharmacy；Laboratory of Medicinal Chemistry(Institute of Organic Chemistry，CSIC)；Departamento de Química Orgánicay Química Inorgánica；Department of Biology and Biotechnology，University of Pavia；Département de Toxicologie et Risques Chimiques，Institut de Recherche Biomédicale des Armées；Department of Animal Anatomy and Preclinical Sciences，University Centre of Veterinary Medicine JU-UA，University of Agriculture in Krakow；Institute of Biochemistry，Faculty of Medicine，University of Ljubljana；Department of Pharmacodynamics，Chair of Pharmacodynamics，Faculty of Pharmacy，Jagiellonian University Medical College；Department of Translational Neurobiology，Neurovascular Research Group，Cajal Institute(CSIC)；Biotechnology and Vegetal Biology Department，Escuela Técnica Superior de Ingeniería Agronómica，Alimentaria y de Biosistemas，Universidad Politécnica de Madrid；Faculty of Health，Camilo José Cela University of Madrid(UCJC)，Neuropsychopharmacology Unit，"Hospital 12 de Octubre" Research Institute）.8-Hydroxyquinolylnitrones as multifunctional ligands for the therapy of neurodegenerative diseases[J].Acta Pharmaceutica Sinica B,2023,第5期 Ruifang Han，Yu Xiao，Qianqian Bai，Chung Hang Jonathan Choi（Department of Biomedical Engineering，the Chinese University of Hong Kong）.Self-therapeutic metal-based nanoparticles for treating inflammatory diseases[J].Acta Pharmaceutica Sinica B,2023,第5期 Kan Xing Wu¹，Thinesshwary Yogarajah^2,3，Marcus Wing Choy Loe²，Parveen Kaur²，Regina Ching Hua Lee²，Chee Keng Mok⁴，Yi Hao Wong⁴，Patchara Phuektes⁵，Li Sze Yeo²，Vincent T.K.Chow^2,3，Yong Wah Tan⁶，Justin Jang Hann Chu^2,5,6,4（Lee Kong Chian School of Medicine，Nanyang Technological University；Department of Microbiology and Immunology，Yong Loo Lin School of Medicine，National University Health System，National University of Singapore；Infectious Disease Programme，Yong Loo Lin School of Medicine，National University of Singapore；NUSMed Biosafety Level 3 Core Facility，Yong Loo Lin School of Medicine，National University of Singapore；Department of Pathobiology，Faculty of Veterinary Medicine，Khonkaen University；Institute of Molecular and Cell Biology，Agency for Science，Technology and Research(A~*STAR)）.The host-targeting compound peruvoside has a broad-spectrum antiviral activity against positive-sense RNA viruses[J].Acta Pharmaceutica Sinica B,2023,第5期 Bin Tu^1,2，Yanrong Gao^1,2，Xinran An^1,3，Huiyuan Wang¹，Yongzhuo Huang^1,2,4,5,6（State Key Laboratory of Drug Research，Shanghai Institute of Materia Medica，Chinese Academy of Sciences；University of Chinese Academy of Sciences；University of Michigan College of Pharmacy；Zhongshan Institute for Drug Discovery，SIMM，CAS；NMPA Key Laboratory for Quality Research and Evaluation of Pharmaceutical Excipients；Taizhou University，School of Advanced Study，Institute of Natural Medicine and Health Product）.Localized delivery of nanomedicine and antibodies for combating COVID-19[J].Acta Pharmaceutica Sinica B,2023,第5期 Huitong Ruan^1,2，Yongfang Li³，Cheng Wang⁴，Yixu Jiang⁴，Yulong Han^5,6，Yiwei Li^5,6，Dandan Zheng¹，Jing Ye⁴，Gang Chen²，Guo-yuan Yang⁴，Lianfu Deng¹，Ming Guo⁵，Xingcai Zhang⁶，Yaohui Tang⁴，Wenguo Cui¹（Department of Orthopaedics，Shanghai Key Laboratory for Prevention and Treatment of Bone and Joint Diseases，Shanghai Institute of Traumatology and Orthopaedics，Ruijin Hospital，Shanghai Jiao Tong University School of Medicine；Jiaxing Key Laboratory of Basic Research and Clinical Translation on Orthopedic Biomaterials，Department of Orthopaedics，the Second Affiliated Hospital of Jiaxing University；Department of Rehabilitation Medicine，Ruijin Hospital，School of Medicine，Shanghai Jiao Tong University；Med-X Research Institute and School of Biomedical Engineering，Shanghai Jiao Tong University；School of Engineering，Massachusetts Institute of Technology；School of Engineering and Applied Sciences，Harvard University）.Click chemistry extracellular vesicle/peptide/chemokine nanocarriers for treating central nervous system injuries[J].Acta Pharmaceutica Sinica B,2023,第5期 Endong Zhang¹，Philana Phan¹，Zongmin Zhao^1,2（Department of Pharmaceutical Sciences，College of Pharmacy，University of Illinois Chicago；Translational Oncology Program，University of Illinois Cancer Center）.Cellular nanovesicles for therapeutic immunomodulation：A perspective on engineering strategies and new advances[J].Acta Pharmaceutica Sinica B,2023,第5期 Rania Awad¹，Avi Avital²，Alejandro Sosnik¹（Laboratory of Pharmaceutical Nanomaterials Science，Department of Materials Science and Engineering，Technion-Israel Institute of Technology；Behavioral Neurobiology Laboratory，Department of Occupational Therapy，Faculty of Social Welfare and Health Sciences，University of Haifa）.Polymeric nanocarriers for nose-to-brain drug delivery in neurodegenerative diseases and neurodevelopmental disorders[J].Acta Pharmaceutica Sinica B,2023,第5期 Yun Teng，Yixue Huang，Hao Yu，Cenhao Wu，Qi Yan，Yingjie Wang，Ming Yang，Haifeng Xie，Tianyi Wu，Huilin Yang，Jun Zou（Department of Orthopaedic Surgery，the First Affiliated Hospital of Soochow University）.Nimbolide targeting SIRT1 mitigates intervertebral disc degeneration by reprogramming cholesterol metabolism and inhibiting inflammatory signaling[J].Acta Pharmaceutica Sinica B,2023,第5期 Shuye Lin¹，Hanli Xu²，Lin Qin³，Mengdi Pang²，Ziyu Wang¹，Meng Gu¹，Lishu Zhang¹，Cong Zhao¹，Xuefeng Hao¹，Zhiyun Zhang¹，Weimin Ding³，Jianke Ren⁴，Jiaqiang Huang^1,2（Cancer Research Center，Beijing Chest Hospital，Capital Medical University，Beijing Tuberculosis and Thoracic Tumor Institute；College of Life Sciences & Bioengineering，Beijing Jiaotong University；Department of Endoscopic Diagnosis and Treatment，Beijing Chest Hospital，Capital Medical University，Beijing Tuberculosis and Thoracic Tumor Institute；CAS Key Laboratory of Computational Biology，Shanghai Institute of Nutrition and Health，University of Chinese Academy of Sciences，Chinese Academy of Sciences）.UHRF1/DNMT1—MZF1 axis-modulated intragenic site-specific CpGI methylation confers divergent expression and opposing functions of PRSS3 isoforms in lung cancer[J].Acta Pharmaceutica Sinica B,2023,第5期 Lijuan Ma¹，Jing Zhang¹，Ling Lin¹，Tuanjie Wang²，Chaofu Ma¹，Xiaomeng Wang¹，Mingshuang Li¹，Yanjiang Qiao¹，Yongxiang Wang³，Guimin Zhang⁴，Zhisheng Wu¹（Beijing University of Chinese Medicine，Engineering Research Center for Pharmaceutics of Chinese Materia Medica and New Drug Development，Ministry of Education；Jiangsu Kanion Pharmaceutical Co.Ltd.，State Key Laboratory of New Technology in Pharmaceutical Process of Traditional Chinese Medicine；Yangtze River Pharmaceutical (Group) Co.Ltd.，State Pharmaceutical Engineering Technology Research Center of Traditional Chinese Medicine；Lunan Pharmaceutical Group Co.Ltd.，State Key Laboratory of Generic Technology of Traditional Chinese Medicine）.Data-driven engineering framework with AI algorithm of Ginkgo Folium tablets manufacturing[J].Acta Pharmaceutica Sinica B,2023,第5期 Yub Raj Neupane^1,2，Harish K.Handral³，Syed Abdullah Alkaff⁴，Wei Heng Chng^1,5，Gopalakrishnan Venkatesan^1,6，Chenyuan Huang^7,8,9，Choon Keong Lee¹，Jiong-Wei Wang^7,8,9,10，Gopu Sriram¹¹，Rhonnie Austria Dienzo¹²，Wen Feng Lu³，Yusuf Ali^12,13，Bertrand Czarny^4,12，Giorgia Pastorin^1,5,14（Department of Pharmacy，National University of Singapore；Department of Pharmaceutical Sciences and Experimental Therapeutics，the University of Iowa College of Pharmacy；Department of Mechanical Engineering，National University of Singapore；School of Materials Science and Engineering，Nanyang Technological University；Integrative Sciences and Engineering Programme，NUS Graduate School，National University of Singapore；Antimicrobial Resistance Interdisciplinary Research Group(AMR-IRG)，Singapore-MIT Alliance for Research and Technology；Department of Surgery，National University of Singapore；Cardiovascular Research Institute，National University Heart Centre；Nanomedicine Translational Research Programme，Centre for Nano Medicine，Yong Loo Lin School of Medicine，National University of Singapore；Department of Physiology，National University of Singapore；Faculty of Dentistry，National University of Singapore；Lee Kong Chian School of Medicine，Nanyang Technological University；Singapore Eye Research Institute(SERI)，Singapore General Hospital；NUSNNI-Nano Core，National University of Singapore）.Cell-derived nanovesicles from mesenchymal stem cells as extracellular vesicle-mimetics in wound healing[J].Acta Pharmaceutica Sinica B,2023,第5期 Shameer M.Kondengadan，Shubham Bansal，Ce Yang，Dongning Liu，Zach Fultz，Binghe Wang（Department of Chemistry and Center for Diagnostics and Therapeutics，Georgia State University）.Click chemistry and drug delivery：A bird’s-eye view[J].Acta Pharmaceutica Sinica B,2023,第5期 Jiang Xu^1,2，Shuai Guo^1,2，Xianmei Yin¹，Mingqian Li³，He Su⁴，Xuejiao Liao⁵，Qiushi Li²，Liang Le²，Shiyu Chen^1,2，Baosheng Liao⁴，Haoyu Hu²，Juan Lei²，Yingjie Zhu⁶，Xiaohui Qiu⁴，Lu Luo²，Jun Chen，Ruiyang Cheng²，Zhenzhan Chang⁸，Han Zhang⁹，Nicholas Chieh Wu¹⁰，Yiming Guo¹¹，Dianyun Hou¹²，Jin Pei¹，Jihai Gao¹，Yan Hua¹³，Zhihai Huang⁴，Shilin Chen^1,2（Institute of Herbgenomics，State Key Laboratory of Southwest Chinese Medicine Resources，Pharmacy College，Chengdu University of Traditional Chinese Medicine；Institute of Chinese Materia Medica，China Academy of Chinese Medical Sciences；Key Laboratory of Cancer Prevention and Therapy Combining Traditional Chinese and Western Medicine of Zhejiang Province，Zhejiang Academy of Traditional Chinese Medicine，Tongde Hospital of Zhejiang Province；Guangdong Provincial Hospital of Chinese Medicine(the Second Clinical Medical College of Guangzhou University of Chinese Medicine，Guangdong Provincial Hospital of Traditional Chinese Medicine)；Pharmacy College，Shandong University of Traditional Chinese Medicine；Department of Pathology，Memorial Sloan Kettering Cancer Center；Beijing Engineering Research Center of Pediatric Surgery，Engineering and Transformation Center，Beijing Children’s Hospital，National Center for Children’s Health，Capital Medical University；School of Basic Medical Sciences，Peking University；School of Chinese Materia Medica，Tianjin University of Traditional Chinese Medicine；School of Life and Environmental Sciences，the University of Sydney；University of Pittsburgh，Kenneth P.Dietrich School of Arts and Sciences；Agricultural College，Henan University of Science and Technology；Guangdong Provincial Key Laboratory of Silviculture，Protection and Utilization，Guangdong Academy of Forestry）.Genomic, transcriptomic, and epigenomic analysis of a medicinal snake, Bungarus multicinctus, to provides insights into the origin of Elapidae neurotoxins[J].Acta Pharmaceutica Sinica B,2023,第5期 Wei Wei，Qingxuan Zeng，Yan Wang，Xixi Guo，Tianyun Fan，Yinghong Li，Hongbin Deng，Liping Zhao，Xintong Zhang，Yonghua Liu，Yulong Shi，Jingyang Zhu，Xican Ma，Yanxiang Wang，Jiandong Jiang，Danqing Song（Institute of Medicinal Biotechnology，Chinese Academy of Medical Sciences and Peking Union Medical College）.Discovery and identification of EIF2AK2 as a direct key target of berberine for anti-inflammatory effects[J].Acta Pharmaceutica Sinica B,2023,第5期 Yunfei Yin¹，Mingyue Tan¹，Lianhua Han¹，Lei Zhang¹，Yue Zhang¹，Jun Zhang¹，Wanqian Pan¹，Jiaxiang Bai^1,2,3，Tingbo Jiang¹，Hongxia Li¹（Department of Cardiology，the First Affiliated Hospital of Soochow University；Department of Orthopedics，the First Affiliated Hospital of Soochow University；Department of Orthopedics，the First Affiliated Hospital of USTC，Division of Life Sciences and Medicine，University of Science and Technology of China）.The hippo kinases MST1/2 in cardiovascular and metabolic diseases：A promising therapeutic target option for pharmacotherapy[J].Acta Pharmaceutica Sinica B,2023,第5期 Hongjuan Zhang¹，Ying Chen¹，Yu Zhang¹，Luyao Qiao¹，Xiangyin Chi¹，Yanxing Han¹，Yuan Lin¹，Shuyi Si²，Jiandong Jiang^1,2（State Key Laboratory of Bioactive Substance and Function of Natural Medicines，Institute of Materia Medica，Chinese Academy of Medical Sciences and Peking Union Medical College；Institute of Medicinal Biotechnology，Chinese Academy of Medical Sciences and Peking Union Medical College）.Identification of anti-Mycobacterium tuberculosis agents targeting the interaction of bacterial division proteins FtsZ and SepFe[J].Acta Pharmaceutica Sinica B,2023,第5期 Mingyan Li¹，Yaling Wang^1,2，Lingzhi Zhang¹，Changxing Gao¹，Jing J.Li¹，Jiandong Jiang¹，Qing Zhu¹（State Key Laboratory of Bioactive Substance and Function of Natural Medicines，and Beijing Key Laboratory of New Drug Mechanisms and Pharmacological Evaluation Study，Chinese Academy of Medical Sciences and Peking Union Medical College；College of Chinese Materia Medica and Yunnan Key Laboratory of Southern Medicinal Utilization，Yunnan University of Chinese Medicine）.Berberine improves central memory formation of CD8⁺ T cells：Implications for design of natural product-based vaccines[J].Acta Pharmaceutica Sinica B,2023,第5期 Jinmiao Lu，Hao Liu²，Qingtong Zhou^3,4，Ming-Wei Wang^3,4，Zhiping Li（Department of Pharmacy，Children’s Hospital of Fudan University，National Children’s Medical Center；School of Medicine，Ningbo University；Research Center for Deepsea Bioresources；Department of Pharmacology，School of Basic Medical Sciences，Fudan University）.A potentially serious adverse effect of GLP-1 receptor agonists[J].Acta Pharmaceutica Sinica B,2023,第5期 Huiyang Wang，Yueyang Liu，Zhenkun Guo，Minghui Cui，Peng Pang，Jingyu Yang，Chunfu Wu（Department of Pharmacology，Shenyang Pharmaceutical University）.Enhancement of oligodendrocyte autophagy alleviates white matter injury and cognitive impairment induced by chronic cerebral hypoperfusion in rats[J].Acta Pharmaceutica Sinica B,2023,第5期 Rolande Meudom^1,2，Yanxian Zhang¹，Michael A.Vanden Berg³，Lei Zou³，Yi Wolf Zhang^1,2，Matthew J.Webber³，Danny Hung-Chieh Chou¹（Division of Endocrinology and Diabetes，Department of Pediatrics，School of Medicine，Stanford University；Department of Biochemistry，School of Medicine，University of Utah；Department of Chemical Engineering，University of Notre Dame）.Supramolecular approaches for insulin stabilization without prolonged duration of action[J].Acta Pharmaceutica Sinica B,2023,第5期 Wen Zhu¹，Yang Wang¹，Liangyin Lv¹，Hui Wang¹，Wenqiang Shi¹，Zexin Liu¹，Mingzhe Zhou²，Jianwei Zhu¹，Huili Lu¹（Engineering Research Center of Cell and Therapeutic Antibody，Ministry of Education，School of Pharmacy，Shanghai Jiao Tong University；State Key Laboratory of Genetic Engineering，School of Life Science，Fudan University）.Universal chimeric Fcγ receptor T cells with appropriate affinity for IgG1 antibody exhibit optimal antitumor efficacy[J].Acta Pharmaceutica Sinica B,2023,第5期 Libin Pan，Hang Yu，Jie Fu，Jiachun Hu，Hui Xu，Zhengwei Zhang，Mengmeng Bu，Xinyu Yang，Haojian Zhang，Jinyue Lu，Jiandong Jiang，Yan Wang（State Key Laboratory of Bioactive Substance and Function of Natural Medicines，Institute of Materia Medica，Chinese Academy of Medical Sciences/Peking Union Medical College）.Berberine ameliorates chronic kidney disease through inhibiting the production of gut-derived uremic toxins in the gut microbiota[J].Acta Pharmaceutica Sinica B,2023,第4期 Zhihui Han¹，Xiang Gao²，Yuanjie Wang¹，Shuning Cheng¹，Xiaoyan Zhong³，Yong Xu⁴，Xiaozhong Zhou²，Zengli Zhang³，Zhuang Liu¹，Liang Cheng¹（Institute of Functional Nano & Soft Materials(FUNSOM)，Collaborative Innovation Center of Suzhou Nano Science and Technology，Soochow University；Department of Orthopedics，The Second Affiliated Hospital of Soochow University；Department of Environmental Health，School of Public Health，Soochow University；School of Materials and Energy，Guangdong University of Technology）.Ultrasmall iron-quercetin metal natural product nanocomplex with antioxidant and macrophage regulation in rheumatoid arthritis[J].Acta Pharmaceutica Sinica B,2023,第4期 Jiaxuan He¹，Qiao Duan^1,2，Chunyan Ran¹，Ting Fu^1,3，Yuan Liu¹，Weihong Tan^1,3,2（The Cancer Hospital of the University of Chinese Academy of Sciences(Zhejiang Cancer Hospital)，The Key Laboratory of Zhejiang Province for Aptamers and Theranostics，Hangzhou Institute of Medicine(HIM)，Chinese Academy of Sciences；Institute of Molecular Medicine(IMM)，Renji Hospital，Shanghai Jiao Tong University School of Medicine，and College of Chemistry and Chemical Engineering，Shanghai Jiao Tong University；Molecular Science and Biomedicine Laboratory(MBL)，State Key Laboratory of Chemo/Biosensing and Chemometrics，College of Chemistry and Chemical Engineering，College of Biology，Aptamer Engineering Center of Hunan Province，Hunan University）.Recent progress of aptamer-drug conjugates in cancer therapy[J].Acta Pharmaceutica Sinica B,2023,第4期 Zhimei Xing^1,2，Han Gao^1,3，Dan Wang^1,2，Ye Shang^1,2，Tenukeguli Tuliebieke^1,2，Jibao Jiang⁴，Chunxiao Li^1,2，Hong Wang¹，Zhenguo Li⁵，Lifu Jia⁶，Yongsheng Wu⁵，Dandan Wang⁵，Wenzhi Yang^1,2，Yanxu Chang^1,2，Xiaoying Zhang^1,2，Liuwei Xu^1,2，Chao Jiang⁷，Luqi Huang⁷，Xiaoxuan Tian^1,2（State Key Laboratory of Component-Based Chinese Medicine，Tianjin University of Traditional Chinese Medicine；Haihe Laboratory of Modern Chinese Medicine；Jiangsu Key Laboratory for Biodiversity and Biotechnology，College of Life Sciences，Nanjing Normal University；School of Agriculture and Biology，Shanghai Jiao Tong University；Mudanjiang YouBo Pharmaceutical Co.Ltd.；Guizhou Ruihe Pharmaceutical Co.Ltd.；State Key Laboratory of Dao-di Herbs，National Resource Center for Chinese Materia Medica，China Academy of Chinese Medical Sciences）.A novel biological sources consistency evaluation method reveals high level of biodiversity within wild natural medicine：A case study of Amynthas earthworms as "Guang Dilong"[J].Acta Pharmaceutica Sinica B,2023,第4期 Kamila Butowska^1,2，Xuexiang Han¹，Ningqiang Gong¹，Rakan El-Mayta¹，Rebecca M.Haley¹，Lulu Xue¹，Wenqun Zhong³，Wei Guo³，Karin Wang⁴，Michael J.Mitchell^1,5,6,7,8（Department of Bioengineering，University of Pennsylvania；Intercollegiate Faculty of Biotechnology，University of Gda nsk & Medical University of Gda nsk；Department of Biology，University of Pennsylvania；Department of Bioengineering，Temple University；Abramson Cancer Center，Perelman School of Medicine，University of Pennsylvania；Institute for Immunology，Perelman School of Medicine，University of Pennsylvania；Cardiovascular Institute，Perelman School of Medicine，University of Pennsylvania；Institute for Regenerative Medicine，Perelman School of Medicine，University of Pennsylvania）.Doxorubicin-conjugated siRNA lipid nanoparticles for combination cancer therapy[J].Acta Pharmaceutica Sinica B,2023,第4期 Zi-Han Ye¹，Wei-Bang Yu¹，Mu-Yang Huang¹，Jun Chen²，Jin-Jian Lu^1,3,4,5（State Key Laboratory of Quality Research in Chinese Medicine，Institute of Chinese Medical Sciences，University of Macau；Zhongshan School of Medicine，Sun Yat-sen University；Department of Pharmaceutical Sciences，Faculty of Health Sciences，University of Macau；MoE Frontiers Science Center for Precision Oncology，University of Macau；Guangdong-Hong Kong-Macau Joint Lab on Chinese Medicine and Immune Disease Research，University of Macau）.Building on the backbone of CD47-based therapy in cancer：Combination strategies, mechanisms, and future perspectives[J].Acta Pharmaceutica Sinica B,2023,第4期 Yau-tuen Chan¹，Hor-yue Tan^1,2，Yuanjun Lu¹，Cheng Zhang¹，Chien-shan Cheng^1,3，Junyu Wu¹，Ning Wang¹，Yibin Feng¹（School of Chinese Medicine，the University of Hong Kong；Centre for Chinese Herbal Medicine Drug Development，School of Chinese Medicine，Hong Kong Baptist University；Department of Traditional Chinese Medicine，Shanghai Jiaotong University，School of Medicine Affiliated Ruijin Hospital）.Pancreatic melatonin enhances anti-tumor immunity in pancreatic adenocarcinoma through regulating tumor-associated neutrophils infiltration and NETosis[J].Acta Pharmaceutica Sinica B,2023,第4期 Xiaoxi Lv¹，Shanshan Liu²，Chang Liu，Yunxuan Li⁴，Tingting Zhang⁴，Jie Qi⁵，Ke Li⁴，Fang Hua¹，Bing Cui¹，Xiaowei Zhang¹，Yuxin Liu¹，Jiaojiao Yu¹，Jinmei Yu¹，Li Li¹，Xia Li⁵，Zhigang Yao⁶，Bo Huang⁷（State Key Laboratory of Bioactive Substance and Function of Natural Medicines，Institute of Materia Medica，Chinese Academy of Medical Sciences & Peking Union Medical College；National Clinical Research Center for Metabolic Diseases，Key Laboratory of Diabetes Immunology，Ministry of Education，And Department of Metabolism and Endocrinology，The Second Xiangya Hospital of Central South University；Drug Clinical Trial Institution，Children’s Hospital，Capital Institute of Pediatrics；Institute of Medicinal Biotechnology，Chinese Academy of Medical Sciences & Peking Union Medical College；Shandong University；Department of Respiratory Medicine，Beijing Friendship Hospital，Capital Medical University；Institute of Basic Medicine，Chinese Academy of Medical Sciences & Peking Union Medical College）.TRIB3 promotes pulmonary fibrosis through inhibiting SLUG degradation by physically interacting with MDM2[J].Acta Pharmaceutica Sinica B,2023,第4期首页上一页 5 6 7 8 9 下一页尾页共有11页，转到页

期刊文章列表